Unichem Laboratories Limited (UNICHEMLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2875
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Scott Delaney | President & Chief Executive Officer of Unichem Pharmaceuticals (USA), Inc. | 0 | 1969 |
| Vinod Kumar Behl | Head of Projects & Investments | 2.1M | 1950 |
| Sanjay Jain | Chief Financial Officer | 5.6M | 1978 |
| Pradeep Kumar Bhandari | Head of Legal, Company Secretary & Compliance Officer | 10.7M | 1958 |
| Pabitrakumar Kalipada Bhattacharyya | MD & Director | 30.7M | 1969 |
| Dhananjay Sathe | Chief Scientific & Compliance Officer | 0 | N/A |
| Bhagwat S. Dhingra | Chief Executive of Domestic Pharma | 0 | 1963 |
| Jalesh Burye | Chief Quality & Compliance Officer | 0 | N/A |
| Prasad Joshi | Vice President of Human Resources & ER | 0 | 1958 |
| Utkarsh Patil | Chief Manufacturing Officer of Formulations | 0 | N/A |
Unichem Laboratories Limited is an international pharmaceutical company engaged in the development, manufacturing, and commercialization of a wide array of medicinal products. The firm's portfolio features finished pharmaceutical formulations designed to treat numerous health conditions, including those related to gastroenterology, cardiovascular health, diabetes, mental health, neurological disorders, bacterial and other infectious diseases, and pain relief. Beyond these formulations, Unichem also provides active pharmaceutical ingredients (APIs) and offers contract manufacturing solutions. This enterprise was established in 1944 and operates from its corporate headquarters in Mumbai, India.